Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001213900-26-028059
Filing Date
2026-03-16
Accepted
2026-03-16 09:53:53
Documents
2
X0202

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 8134
2 JOINT FILING AGREEMENT ea027720801ex99-1_kamada.htm EX-99.1 4715
  Complete submission text file 0001213900-26-028059.txt   14412
Mailing Address MEDINAT HAYEHUDIM STREET 85 8TH FLOOR HERZELIA PITUAH L3 L3
Business Address
RECANATI LEON (Filed by) CIK: 0000919590 (see all company filings)

State of Incorp.: NY | Fiscal Year End: 1231
Type: SCHEDULE 13G/A
SIC: 0000

Mailing Address 2 HOLTZMAN ST., SCIENCE PARK REHOVOT L3 7670402
Business Address 2 HOLTZMAN ST., SCIENCE PARK REHOVOT L3 7670402 97289406472
KAMADA LTD (Subject) CIK: 0001567529 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-87516 | Film No.: 26754864
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)